Objective To explore the risk factors, pathogenic bacteria, drug resistance and corresponding measures of prevention and treatment on lower respiratory tract infection caused by extended-spectrum beta-lactamase-producing bacteria (ESBLPB) in neonates. Methods The patieats were from the neonatal intensive care unit(NICU) of The First People's Hospital of Zhaoqing from Jan. 1998 to Apr. 2001. The secretions of the lower respiratory tract were collected, and bacterial culture and antimicrobial susceptibility testing were done. Results There were 23 positive cases in the 42 cultured cases, and 12 cases out of 23 cases were ESBLPB positive. The positive rate of ESBLPB was 52%(12/23). Of them, 9 cases (75%) had the history of using the third generation cephalosporins, 10(83%) were under mechanical ventilations, 8(67%) were lowbirth weight infants and/or premature infants. There were 21 strains in 12 cases. They were 8(38%)Klebsiella pneumoniae, 5(24%)Enterobacter cloacae, 3(14%) Escherichia coli, 3(14%) Pseudomonas aeruginosa, 1(5%)Stenotrophomonas maltophilia, 1(5%) brevi-flavobacterium strains. The ESBLPBs were sensitive to imipenem, ciprofloxacin, amikacin, levofloxacin, ticarcillin-clavulanic acid, meropenem, piperacillin but resistant to other antibiotics. Ten out of the 12 cases were fully recovered from their infection. Conclusion There are multiple factors to increase the lower respiratory tract infections caused by ESBLPB in neonates. The effective measures associated with the infection prevention include intensive sterilization and isolation, and timely immunigation.

Sialidosis is a rare autosomal recessive disorder which is classified into type Ⅰ and Ⅱ according to the age of onset and severity of the disease.Type I,also known as mucolipidosis,is often manifested as myoclonus,ataxia,general tonic clonic seizure,and bilateral cherry-red spots in eye examination.Four cases of type Ⅰ sialidosis were reported in order to improve the diagnosis and treatment of this disease.Patients were mainly manifested as myoclonus and ataxia.Whole exon gene sequencing of the four patients all showed the mutation c.544A＞G in the NEU1 gene.Meanwhile,the new mutation c.596G＞A carried was found in case 2 and its pathogenicity was also analyzed.Finally,we summarized the clinical characteristics of type Ⅰ patients in China,noting that most patients develop all the core symptoms as the disease progresses.